Search
for
Sort by
Research 241–270 of 263
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Abstracts from the 2024 WDS Forum - virtual option
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Recent Advances in Drug Development for Hair Loss
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Baricitinib as a treatment for myasthenia gravis: A case report
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 1,314
- Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study